| Literature DB >> 17290444 |
Abstract
This article reviews the performance of first trimester screening for chromosomal anomalies using various combinations of ultrasound and maternal serum biochemical modalities. Detection rates in excess of 90% can be routinely achieved for Trisomy 21, Trisomy 13, Trisomy 18 using a combination of fetal nuchal translucency (NT) thickness and maternal serum free ss-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks of gestation. (c) 2007 Wiley-Liss, Inc.Entities:
Mesh：
Substances：
Year: 2007 PMID： 17290444 DOI： 10.1002/ajmg.c.30119
Source DB: PubMed Journal: Am J Med Genet C Semin Med Genet ISSN： 1552-4868 Impact factor: 3.908